CClinicalTrials.gg
Not yet recruitingNCT06587711Updated Sep 19, 2024

Application of Cheek Acupuncture in Vaginal Tightening Surgery

An interventional study of acupuncture treatment in Pain Vulva, sponsored by The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. Not yet recruiting at 1 site in China. Open to female participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Feb 2025, 1 year 8 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
Female
01

Study summary

A large number of studies have shown that acupuncture can reduce perioperative pain in patients. Cheek acupuncture therapy is a new acupuncture treatment, which belongs to the microneedle system, that is, acupuncture at specific acupoint on the face, which can relieve patients' pain. In this study, the efficacy and safety of cheek acupuncture in patients undergoing vaginal tightening surgery was verified by observing the consumption of opioid, intraoperative hemodynamics, dosage of oral remedial analgesics, postoperative quality of recovery, patient satisfaction, incidence of side effects, etc.

02

Conditions studied

  • Pain Vulva

Browse trials for

Keywords

  • Acupuncture
  • Analgesia
  • Vaginal tighting surgery
03

In context

Vulvodynia

106 studies on the registry are indexed under Vulvodynia; 21 are open to participants now.

This study's planned enrollment of 60 is above the median of 44 across 79 interventional studies indexed under Vulvodynia.

Browse Vulvodynia studies →

Lead sponsor

The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Patients aged 18-60 years, undergoing vaginal tightening surgery
  • American Society of Anesthesiologists (ASA) physical status I to II
  • Voluntary participation and signed an informed consent form

Exclusion criteria

Exclusion Criteria:

  • Acute and/or chronic pain before surgery
  • History of congenital heart disease, arrhythmia, or hypertension
  • History of severe mental or neurological diseases, drug or psychotropic drug abuse
  • Cognitive dysfunction or inability to communicate.
  • The acupuncture acupoints are infected
  • Coagulation disorders
  • Patients with mandibular or zygomatic bone osteotomy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    cheek acupuncture treatmnet

    Patients in the experimental group are treated with cheek acupuncture.

    Procedure: acupuncture treatment

  • Sham comparator
    sham acupuncture treatment

    Patients in the control group are treated with sham acupuncture.

    Procedure: acupuncture treatment

Interventions

  • Procedureacupuncture treatment

    Patients in experimental group received acupuncture at specific acupoint on the face, patients in control group received sham acupuncture at non-acupoint on the face.

06

What researchers measure

Primary outcomes

  1. Intraoperative opioid consumption

    Intraoperative remifentanil dosage Intraoperative remifentanil dosage Intraoperative remifentanil consumption

    Time frame: End of surgery

Secondary outcomes

  1. Patient intravenous controlled analgesia (PCIA) pump consumption

    PCIA pump consumption in 24 hours after surgery

    Time frame: 24 hours after surgery

  2. the rest numerical rating scale (NRS) scores

    0\~11,a higher score means a better outcome

    Time frame: 24 hours after surgery, 48 hours after surgery

  3. the coughing numerical rating scale (NRS) scores

    0\~11,a higher score means a better outcome

    Time frame: 24 hours after surgery, 48 hours after surgery

  4. 15-item quality of recovery (QoR-15)

    0\~150, a higher score means a better outcome

    Time frame: 1 day after surgery, 2 day after surgery

  5. Athens Insomnia Scale (AIS)

    0\~24, a lower score means a better outcome

    Time frame: 24 hours after surgery, 48 hours after surgery

  6. Hospital Anxiety and Depression Scale(HADS)

    HADS(A) and HADS(D), 0\~21, respectively, a lower score means a better outcome

    Time frame: 24 hours after surgery, 48 hours after surgery

  7. Patient satisfaction

    patient satisfaction on a Likert scale (1\~5,a higher score means a better satisfaction)

    Time frame: 48 hours after surgery

  8. Systolic blood pressure (SBP)

    Intraoperative hemodynamics

    Time frame: Enter the operating room,15 minutes after anesthesia administration, surgery onset, 1 hour of surgery, end of surgery

  9. Diastolic blood pressure (DBP)

    Intraoperative hemodynamics

    Time frame: Enter the operating room,15 minutes after anesthesia administration, surgery onset, 1 hour of surgery, end of surgery

  10. Mean blood pressure (MBP)

    Intraoperative hemodynamics

    Time frame: Enter the operating room,15 minutes after anesthesia administration, surgery onset, 1 hour of surgery, end of surgery

  11. Heart rate (HR)

    Intraoperative hemodynamics

    Time frame: Enter the operating room,15 minutes after anesthesia administration, surgery onset, 1 hour of surgery, end of surgery

  12. Opioid-related side effects

    postoperative nausea and vomiting (PONV), dizziness, headache, pruritus, and respiratory depression

    Time frame: 0~48 hours after surgery

  13. Acupuncture-related side effects

    hematoma,infection

    Time frame: 0~48 hours after surgery

  14. Intraoperative dexmedetomidine consumption

    Time frame: End of surgery

  15. Intraoperative midazolam consumption

    Time frame: End of surgery

  16. Respiratory rates (RR)

    Time frame: Enter the operating room,15 minutes after anesthesia administration, surgery onset, 1 hour of surgery, end of surgery

  17. the partial pressure of end-tidal carbon dioxide (PetCO2)

    Time frame: Enter the operating room,15 minutes after anesthesia administration, surgery onset, 1 hour of surgery, end of surgery

07

Study locations

1 site
  • Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
    Beijing, Beijing 010, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06587711
Lead sponsor
The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Responsible party
Chunmei Chen (Attending physician, The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College) — Principal investigator
First posted
Sep 19, 2024
Start date
Sep 2024 (estimated)
Primary completion
Feb 2025 (estimated)
Completion
Feb 2025 (estimated)
Last update
Sep 19, 2024

Study contacts

Chen Chunmei, doctorate
Contact
chunmeichen2008@163.com
+8618611612186
Yang Dong, doctorate
study chair · Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion